UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

The Lancet (British edition), 2010-08, Vol.376 (9742), p.687-697

2010

Volltextzugriff (PDF)

Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment of HER2-Amplified Advanced Gastric Cancer in Asian Populations: TyTAN— A Randomized, Phase III Study

Journal of clinical oncology, 2014-07, Vol.32 (19), p.2039-2049

2014

Volltextzugriff (PDF)

Characteristics and outcomes of coronavirus disease 2019 (COVID-19) patients with cancer: a single-center retrospective observational study in Tokyo, Japan

International journal of clinical oncology, 2021-03, Vol.26 (3), p.485-493

2021

Volltextzugriff (PDF)

Ramucirumab for the treatment of metastatic gastric or gastroesophageal junction adenocarcinoma following disease progression on first-line platinum- or fluoropyrimidine-containing combination therapy in Japanese patients: a phase 2, open-label study

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2018-11, Vol.21 (6), p.1041-1049

2018

Volltextzugriff (PDF)

Transcriptomic profiling of single circulating tumor cells provides insight into human metastatic gastric cancer

Communications biology, 2022-01, Vol.5 (1), p.20-20, Article 20

2022

Volltextzugriff (PDF)

Synchronous multiple primary tumors in patients with malignant lymphoma: a retrospective study

BMC cancer, 2022-06, Vol.22 (1), p.640-640, Article 640

2022

Volltextzugriff (PDF)

A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2)

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2019-03, Vol.22 (2), p.344-354

2019

Volltextzugriff (PDF)

Phase IIb study of pembrolizumab combined with S‐1 + oxaliplatin or S‐1 + cisplatin as first‐line chemotherapy for gastric cancer

Cancer science, 2022-08, Vol.113 (8), p.2814-2827

2022

Volltextzugriff (PDF)

Phase I/II Study: Experience with the Late Onset of Acute Pancreatitis after the Start of Chemotherapy with Gemcitabine Plus nab-Paclitaxel for Metastatic Pancreatic Cancer

Internal Medicine, 2019/10/15, Vol.58(20), pp.2957-2962

2019

Volltextzugriff (PDF)

Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2016-07, Vol.19 (3), p.927-938

2016

Volltextzugriff (PDF)

Phase II study of cetuximab plus S-1/cisplatin therapy in Japanese patients with advanced gastric cancer

Japanese journal of clinical oncology, 2021-06, Vol.51 (6), p.879-885

2021

Volltextzugriff (PDF)

Regional differences in advanced gastric cancer: exploratory analyses of the AVAGAST placebo arm

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2018-05, Vol.21 (3), p.429-438

2018

Volltextzugriff (PDF)

A new prognostic score comprising lactate dehydrogenase, albumin and neutrophil to lymphocyte ratio to predict sensitivity to first-line chemotherapy in patients with peripheral T-cell lymphomas

International journal of hematology, 2018-04, Vol.107 (4), p.451-459

2018

Volltextzugriff (PDF)

Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2012-07, Vol.15 (3), p.313-322

2012

Volltextzugriff (PDF)

Modified FOLFOX-6 Plus Bevacizumab Chemotherapy for Metastatic Colorectal Cancer in Patients Receiving Hemodialysis: A Report of Three Cases and Review of the Literature

Case reports in oncology, 2019-08, Vol.12 (2), p.657-665

2019

Volltextzugriff (PDF)

Relative dose intensity of R‐CHOP therapy and patient outcomes in advanced follicular lymphoma

Hematological oncology, 2019-08, Vol.37 (3), p.303-307

2019

Volltextzugriff (PDF)

Multimodal Treatment of Extragonadal Choriocarcinoma with Multiple Brain and Lung Metastases: A Case Report

Case reports in oncology, 2019-09, Vol.12 (3), p.928-934

2019

Volltextzugriff (PDF)

Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2013-04, Vol.16 (2), p.175-182

2013

Volltextzugriff (PDF)

Geriatric nutritional risk index as a prognostic factor in patients with diffuse large B cell lymphoma

Annals of hematology, 2018-06, Vol.97 (6), p.999-1007

2018

Volltextzugriff (PDF)

A Case of Acute Megakaryocytic Leukemia Associated with A Nonseminomatous Primary Mediastinal Germ Cell Tumor Diagnosed through Elevation of Serum Lactate Dehydrogenase

International Journal of Case Reports and Images (IJCRI), 2015-11, Vol.6 (11), p.xiii+720-723

2015

Volltextzugriff (PDF)

Phase I/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancer

Cancer chemotherapy and pharmacology, 2016-03, Vol.77 (3), p.595-603

2016

Volltextzugriff (PDF)

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer

The New England journal of medicine, 2020-06, Vol.382 (25), p.2419-2430

2020

Volltextzugriff (PDF)

Clinical impact of controlling nutritional status score on the prognosis of patients with diffuse large B‐cell lymphoma

Hematological oncology, 2020-08, Vol.38 (3), p.309-317

2020

Volltextzugriff (PDF)

Impact of pegfilgrastim approval on relative dose intensity and outcomes of R-CHOP for diffuse large B-cell lymphoma

Medicine (Baltimore), 2022-03, Vol.101 (10), p.e29028

2022

Volltextzugriff (PDF)

Safety and efficacy of pembrolizumab in combination with S-1 plus oxaliplatin as a first-line treatment in patients with advanced gastric/gastroesophageal junction cancer: Cohort 1 data from the KEYNOTE-659 phase IIb study

European journal of cancer (1990), 2020-04, Vol.129, p.97-106

2020

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(80)

Publikationsform

Artikel
(85)
Berichte
(4)

Sprache

Englisch
(83)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Humans
(42)
Science & Technology
(42)
Life Sciences & Biomedicine
(41)
Aged
(33)
Female
(33)
Oncology
(33)
Male
(32)
Middle Aged
(31)
Adult
(27)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(24)
Medicine
(17)
Medicine & Public Health
(17)
Aged, 80 And Over
(16)
Chemotherapy
(16)
Stomach Neoplasms - Drug Therapy
(16)
Gastric Cancer
(14)
Patients
(14)
Prognosis
(14)
Cancer Research
(13)
Original Article
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment of HER2-Amplified Advanced Gastric Cancer in Asian Populations: TyTAN— A Randomized, Phase III Study

Characteristics and outcomes of coronavirus disease 2019 (COVID-19) patients with cancer: a single-center retrospective observational study in Tokyo, Japan

Ramucirumab for the treatment of metastatic gastric or gastroesophageal junction adenocarcinoma following disease progression on first-line platinum- or fluoropyrimidine-containing combination therapy in Japanese patients: a phase 2, open-label study

Transcriptomic profiling of single circulating tumor cells provides insight into human metastatic gastric cancer

Synchronous multiple primary tumors in patients with malignant lymphoma: a retrospective study

A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2)

Phase IIb study of pembrolizumab combined with S‐1 + oxaliplatin or S‐1 + cisplatin as first‐line chemotherapy for gastric cancer

Phase I/II Study: Experience with the Late Onset of Acute Pancreatitis after the Start of Chemotherapy with Gemcitabine Plus nab-Paclitaxel for Metastatic Pancreatic Cancer

Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer

Phase II study of cetuximab plus S-1/cisplatin therapy in Japanese patients with advanced gastric cancer

Regional differences in advanced gastric cancer: exploratory analyses of the AVAGAST placebo arm

A new prognostic score comprising lactate dehydrogenase, albumin and neutrophil to lymphocyte ratio to predict sensitivity to first-line chemotherapy in patients with peripheral T-cell lymphomas

Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study

Modified FOLFOX-6 Plus Bevacizumab Chemotherapy for Metastatic Colorectal Cancer in Patients Receiving Hemodialysis: A Report of Three Cases and Review of the Literature

Relative dose intensity of R‐CHOP therapy and patient outcomes in advanced follicular lymphoma

Multimodal Treatment of Extragonadal Choriocarcinoma with Multiple Brain and Lung Metastases: A Case Report

Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study

Geriatric nutritional risk index as a prognostic factor in patients with diffuse large B cell lymphoma

A Case of Acute Megakaryocytic Leukemia Associated with A Nonseminomatous Primary Mediastinal Germ Cell Tumor Diagnosed through Elevation of Serum Lactate Dehydrogenase

Phase I/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancer

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer

Clinical impact of controlling nutritional status score on the prognosis of patients with diffuse large B‐cell lymphoma

Impact of pegfilgrastim approval on relative dose intensity and outcomes of R-CHOP for diffuse large B-cell lymphoma

Safety and efficacy of pembrolizumab in combination with S-1 plus oxaliplatin as a first-line treatment in patients with advanced gastric/gastroesophageal junction cancer: Cohort 1 data from the KEYNOTE-659 phase IIb study

Suchergebnisse filtern